Co-administration of oral killed whole-cell recombinant cholera toxin B-subunit vaccine (WC-rCTB) and live <i>Salmonella</i> Typhi Ty21a vaccine: a prospective randomized open-label trial
Co-administration of the oral cholera and typhoid vaccines demonstrated favourable safety and robust immunogenicity for both vaccines, supporting their simultaneous use without spacing precautions.
Authors
- Tero J. Vahlberg (ORCID: https://orcid.org/0000-0002-4935-3056)
- Manuela Terrinoni (ORCID: https://orcid.org/0000-0002-2664-3210)
- Marianna Riekkinen
- Anu Kantele (ORCID: https://orcid.org/0000-0002-0004-1000)
- Anna Lundgren (ORCID: https://orcid.org/0000-0001-6491-4977)
- Sari H. Pakkanen (ORCID: https://orcid.org/0000-0003-4522-5337)
- Joanna Kaim
Institutions
- University of Helsinki (FI)
- University of Turku (FI)
- Helsinki University Hospital (FI)
- Turku University Hospital (FI)
- Institute for Biomedicine (IT)
- University of Gothenburg (SE)
Publication Details
- Journal
- Journal of Travel Medicine
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1093/jtm/taag008
- Primary Topic
- Vibrio bacteria research studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00